Lv1
30 积分 2025-08-22 加入
Cost-effectiveness of datopotamab deruxtecan in previously treated advanced nonsquamous NSCLC
1个月前
已完结
Comprehensive analysis of patient and caregiver predictors for caregiver burden, anxiety and depression in Alzheimer's disease
1个月前
已完结
Multidimensional burden of caregivers of Alzheimer's disease and related dementia in China: A nationwide cross-sectional study
1个月前
已完结
1469MO Liver resection versus continued atezolizumab plus bevacizumab (atezo/bev) in locally advanced hepatocellular carcinoma (HCC) after atezo/bev treatment (TALENTop): A multicenter, open-label, randomized phase III trial
1个月前
已完结
Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil*
2个月前
已完结
Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial)
2个月前
已完结
Cost-Effectiveness of Donanemab for Early Alzheimer Disease in Australia
2个月前
已完结
Cost Effectiveness of Memantine in???Moderately Severe to Severe Alzheimer???s Disease
2个月前
已完结
The cost of Alzheimer's disease in China and re‐estimation of costs worldwide
2个月前
已完结
Population Norms for SF-6Dv2 and EQ-5D-5L in China
2个月前
已完结
皖公网安备34019202002308
